We are live on ! Find out more
CG

Column Group Portfolio holdings

AUM $88.1M
1-Year Est. Return 148.03%
This Fund
S&P 500
This Quarter Est. Return
+37.74%
1 Year Est. Return
+148.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+23.89%
10 Year Est. Return
–
AUM
$65.7M
AUM Growth
+$21.5M
Cap. Flow
+$8.87M
Cap. Flow %
13.49%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RAPT
RAPT Therapeutics
RAPT
+$8.87M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORIC icon
1
Oric Pharmaceuticals
ORIC
$1.44B
$35.9M 54.68%
3,540,777
– –
SRZN icon
2
Surrozen
SRZN
$282M
$13.4M 20.4%
1,499,773
– –
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$10.6M 16.17%
1,328,613
+1,162,536
+700% +$8.87M
TNYA icon
4
Tenaya Therapeutics
TNYA
$163M
$5.74M 8.74%
9,400,290
– –
RVMD icon
5
Revolution Medicines
RVMD
$43.7B
$1.69K ﹤0.01%
46
– –

Similar funds

PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return
FWM
FSR Wealth Management Elmhurst, Illinois $87.8M AUM 10.63% 1-Year Est. Return
WP
Walleye Partners Madison, Wisconsin $87.7M AUM
SHCM
Stone House Capital Management Bay Harbor Islands, Florida $88.5M AUM 149.16% 1-Year Est. Return
YIM
Yoffe Investment Management Lemoyne, Pennsylvania $87.4M AUM 30.8% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
LC
Luminist Capital Grand Rapids, Michigan $89M AUM 17.66% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Column Group's Q2 2025 Portfolio in Review

As of Q2 2025, Column Group held 5 positions worth $65.7M, up 49% from $44.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Column Group deployed $8.87M of net new capital in Q2 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group added most to RAPT Therapeutics in Q2 2025, an estimated $8.87M increase.
  • Column Group's ten largest holdings make up 100% of its $65.7M portfolio in Q2 2025.
  • Column Group opened 0 new positions and closed 0 in Q2 2025.
  • Column Group's portfolio value rose 49% quarter-over-quarter to $65.7M.

Based on Column Group's 13F filing for Q2 2025, filed 15 Aug 2025.